Having breast cancer placed a significantly greater financial strain on black women than white women, according to a study by researchers at the University of North Carolina Lineberger Comprehensive Cancer Center.

On May 30, 2018, the American College of Radiology (ACR) Data Science Institute (DSI) and the Society for Imaging Informatics in Medicine (SIIM) will hold the Spring 2018 Data Science Summit: Economics of Artificial Intelligence (AI) in Health Care. The summit will be hosted at the SIIM 2018 Annual Meeting, May 31-June 2 in National Harbor, Md.

Imaging Technology News (ITN) was honored with a pair of National Bronze Azbee Awards for editorial excellence at the 2018 American Society of Business Publication Editors (ASBPE) Azbee Awards of Excellence banquet in Washington, D.C. Both ITN awards were in recognition of the efforts of Contributing Editor Greg Freiherr — in the Regular Column, Contributed category for Freiherr’s monthly column “The Last Read,” and in the Online Video News category for his Technology Report: Enterprise Imaging from the 2016 Radiological Society of North America (RSNA) annual meeting.

Damage to some of the pathways that carry information throughout the brain may be responsible for attention deficit in patients who have had a subcortical stroke in the brain's right hemisphere. These conclusions are drawn from a study published online in the journal Radiology. Researchers hope the findings may provide a measure for selecting suitable patients for early interventions aimed at reducing cognitive decline following stroke.

Teleradiology company DocPanel announced a partnership with the University of Southern California (USC) Keck School of Medicine Department of Radiology that will give consumers access to Keck's 60 radiology subspecialists. DocPanel enables imaging centers to use USC experts who are focused on specific areas of the body, therefore providing unique perspective and accurate insights.

Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in radiopharmaceuticals and radiopharmaceutical technologies. Under the terms of the agreement, Blue Earth Diagnostics has acquired the exclusive worldwide rights to a broad family of prostate specific membrane antigen (PSMA)-targeted radiohybrid (“rh”) agents for cancer imaging, together with an exclusive option to explore therapeutic applications.

The U.S. Preventive Services Task Force (USPSTF) posted a final recommendation statement and evidence summaries on screening for prostate cancer. This final recommendation provides clinicians and their patients with important new information about the benefits and harms of prostate-specific antigen (PSA)-based screening.